Agilent partners with Medication Monitoring Specialist

Agilent Technologies and Ameritox have formed a research collaboration that could accelerate analysis in the field of medication monitoring. “By using multiple Rapid Fire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s Rapid Fire business.

While the RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration marks one of the first steps into medication monitoring with Ameritox, which provides dedicated laboratory testing and reporting services in this field.

“By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox.

“The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” he added.